A Multicenter Randomized Phase III, Double-Blind Study Comparing Efficacy of the Association of Exemestane and Celecoxib Versus Exemestane and Placebo in Menopausal Patients With Metastatic Breast Cancer
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Celecoxib; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms CELAROM
- 30 Jun 2011 Biomarkers information updated
- 19 Sep 2007 New trial record.